Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis: The OPERA I and II Randomized Clinical Trials jamanetwork.com/journals/jam... #hvhebron #nimm [Text complet]

Spinal cord imaging in multiple sclerosis: from diagnosis to disease progression link.springer.com/article/10.1... #hvhebron #nimm [Text complet]

An integrated framework for clinical surveillance in multiple sclerosis: An evidence-informed narrative review. www.sciencedirect.com/science/arti... #hvhebron #nimm

Use of MRI in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease - MAGNIMS consensus recommendations. www.nature.com/articles/s41... #hvhebron #nimm #rad

Use of patient reported outcomes in multiple sclerosis clinical management: Scoping literature review. journals.sagepub.com/doi/10.1177/... #hvhebron #nimm

Cognitive Resilience and Improvements in Health-Related Quality of Life Over 4 Years in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results from the CLARIFY-MS Extension Study www.sciencedirect.com/science/arti... #hvhebron #nimm

Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS. jnnp.bmj.com/content/earl... #hvhebron #nimm #mprev [Text complet]

Dorsolateral nigral hyperintensity in idiopathic REM sleep behavior disorder: a systematic review and meta-analysis. www.sciencedirect.com/science/arti... #hvhebron #nimm [Text complet]

Evaluation of the 2022 international consensus criteria for optic neuritis: the role of clinical features and visual evoked potentials. link.springer.com/article/10.1... #hvhebron #nimm #rad #nfis